Research on Body Voice AI Recognition System for Children's Health Management
Intelligent Voice Model: A New Paradigm Exploration for Child Health Management
1 other identifier
observational
30,000
1 country
5
Brief Summary
The purpose of this research is to develop a body voice artificial intelligence (AI) recognition device, also referred to as an AI-assisted body sound identification device, by utilizing a deep learning-based novel AI algorithm in conjunction with a big body voice model. It could identify normal and abnormal heart, breath, and bowel sounds, and to provide early screening and auxiliary diagnosis of congenital heart disease (CHD), respiratory infections, diarrhea and other common multi-occurring diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2024
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 4, 2024
CompletedFirst Posted
Study publicly available on registry
August 7, 2024
CompletedStudy Start
First participant enrolled
August 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedAugust 7, 2024
April 1, 2024
11 months
August 4, 2024
August 6, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Sensitivity
Sensitivity in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation
1 month
Specificity
Specificity in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation
1 month
AUC
AUC in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation
1 month
Study Arms (1)
0 ~ 18 years old children
Age range: 0 to 18 years old, with no gender restriction. Children who have been diagnosed with congenital heart disease (CHD) or confirmed to be free of CHD through echocardiographic examinations. Children who have been diagnosed with bronchopneumonia or confirmed to be free of bronchopneumonia through chest imaging examinations. Children who have been diagnosed with abdominal diseases or confirmed to be free of abdominal diseases through abdominal imaging examinations.
Interventions
Heart auscultation will be done by pediatrician and echocardiography by echocardiologist
Chest auscultation will be done by pediatrician and chest imaging examinations by radiologist
Abdominal auscultation will be done by pediatrician and chest imaging examinations by radiologist
Eligibility Criteria
1. Children (0-18 years old) with congenital heart disease confirmed by cardiac ultrasound and children without congenital heart disease confirmed by cardiac ultrasound. 2. Children (0-18 years old) with bronchopneumonia confirmed by chest imaging examination and children without bronchopneumonia confirmed by imaging. 3. Children (0-18 years old) with abdominal imaging confirmed abdominal disease and children diagnosed without abdominal disease by imaging.
You may qualify if:
- Age 0\~18 years old, gender is not limited
- Children who have been diagnosed with congenital heart disease by cardiac ultrasound or who do not have congenital heart disease
- Children diagnosed with bronchopneumonia or without bronchopneumonia
- Children who are clinically diagnosed with intestinal diseases or who do not suffer from intestinal diseases
- Informed consent
You may not qualify if:
- ≥ 18 years old
- Children who are unable to undergo cardiac ultrasound, chest imaging or other related examinations
- Subjects who are unable to obtain informed consent, or who are unwilling to cooperate with the provision of diagnosis and treatment related data for further analysis and research as required by the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430016, China
Human Children's Hospital
Changsha, Hunan, 410007, China
Xinhua Hospital,Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200092, China
Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, 200127, China
Kunming children's Hospital
Kunming, Yunnan, 650028, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xin Sun, MD
Xinhua Hospital, Shanghai J iao Tong University School of Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2024
First Posted
August 7, 2024
Study Start
August 21, 2024
Primary Completion
July 31, 2025
Study Completion
December 30, 2025
Last Updated
August 7, 2024
Record last verified: 2024-04